Serotonin-induced enhancement of vasopressin and oxytocin secretion in rat neurohypophyseal tissue culture

Regulatory Peptides

Volumn 127, Issue 1-3, 2005, Pages 225-231

  Galfi M ^a   Radacs M ^a   Juhasz A ^a   Laszlo F ^b   Molnar A ^a   Laszlo F A ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Ketanserin; Metergoline; Neurohypophyseal tissue culture; Oxytocin; Serotonin antagonist; Serotonin regulation; Vasopressin; WAY 100635

Indexed keywords

KETANSERIN; METERGOLINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; NEUROHYPOPHYSIS HORMONE; OXYTOCIN; SEROTONIN; SEROTONIN ANTAGONIST; UNCLASSIFIED DRUG; VASOPRESSIN;

ANIMAL TISSUE; ARTICLE; HORMONE RELEASE; MALE; NEUROHYPOPHYSIS; NONHUMAN; OXYTOCIN RELEASE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SEROTONINERGIC SYSTEM; SUPERNATANT; TISSUE CULTURE; VASOPRESSIN RELEASE;

ANIMALS; KETANSERIN; MALE; METERGOLINE; OXYTOCIN; PIPERAZINES; PITUITARY GLAND, POSTERIOR; PYRIDINES; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN ANTAGONISTS; TIME FACTORS; TISSUE CULTURE TECHNIQUES; VASOPRESSINS;

EID: 13144258767     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2004.12.009     Document Type: Article

References (45)

1. F.A. László, M. Gálfi, I. Jójárt, M. Vecsernyés, F. Laczi, and K. Maderschpach Neurohypophysis tissue culture as a model of hormonal activity of rat pituicytes Proc. 4th Int. Conf. Neurohypophysis, New Aspects of Morphology Function and Regulation 1989 Oxford Univ. Press Copenhagen 87 91
2. T. Janáky, P. Szabo, Z. Kele, L. Balaspiri, C. Varga, and M. Galfi Identification of oxytocin and vasopressin from neurohypophyseal cell culture Rapid Commun. Mass Spectrom. 12 1998 1765 1768
3. E. Mohr, A. Zhou, N.A. Thorn, and D. Richter Rats with physically disconnected hypothalamo-pituitary tracts no longer contain vasopressin-oxytocin gene transcripts in the posterior pituitary lobe FEBS Lett. 263 1990 332 336
4. C.J. Boersma, M.A. Sonnemans, and F.W. Van Leeuwen Immunoelectron microscopic demonstration of oxytocin and vasopressin in pituicytes and in nerve terminals forming synaptoid contacts with pituicytes in the rat neural lobe Brain Res. 611 1993 117 129
5. C.D. Tweedle, and G.I. Hatton Morphological adaptability at neurosecretory axonal endings on the neurovascular contact zone of the rat neurohypophysis Neuroscience 20 1987 241 246
6. N. Falke Modulation of oxytocin and vasopressin release at the level of the neurohypophysis Prog. Neurobiol. 36 1991 465 484
7. S. Reichlin Neuroendocrinology J.D. Wilson D.W. Foster H.M. Kronenberg P.R. Larsen Textbook of endocrinology 1998 Philadelphia 165 248
8. C.F. Ferris, R.H. Melloni Jr., G. Koppel, K.W. Perry, R.W. Fuller, and Y. Delville Vasopressin/serotonin interactions in the anterior hypothalamus control aggressive behavior in golden hamsters J. Neurosci. 17 1997 4331 4340
9. P.E. Sawchenko, L.W. Swanson, H.W. Steinbusch, and A.A. Verhofstad The distribution and cells of origin of serotonergic inputs to the paraventricular and supraoptic nuclei of the rat Brain Res. 277 1983 355 360
10. C.F. Ferris, and Y. Delville Vasopressin and serotonin interactions in the control of agonistic behavior Psychoneuroendocrinology 19 1994 593 601
11. L.D. Van de Kar, A. Javed, Y. Zhang, F. Serres, D.K. Raap, and T.S. Gray 5-HT2A receptors stimulate ACTH, corticosterone, oxytocin, renin, and prolactin release and activate hypothalamic CRF and oxytocin-expressing cells J. Neurosci. 21 2001 3572 3579
12. P.E. Pergola, A.F. Sved, J.L. Voogt, and R.H. Alper Effect of serotonin on vasopressin release: a comparison to corticosterone, prolactin and renin Neuroendocrinology 57 1993 550 558
13. H. Jorgensen, A. Kjaer, U. Knigge, M. Moller, and J. Warberg Serotonin stimulates hypothalamic mRNA expression and local release of neurohypophysial peptides J. Neuroendocrinol. 15 2003 564 571
14. M. Iovino, and L. Steardo Effect of substances influencing brain serotonergic transmission on plasma vasopressin levels in the rat Eur. J. Pharmacol. 113 1985 99 103
15. L.D. Van de Kar Neuroendocrine pharmacology of serotonergic (5-HT) neurons Annu. Rev. Pharmacol. Toxicol. 31 1991 289 320
16. H. Jorgensen, U. Knigge, A. Kjaer, and J. Warberg Serotonergic involvement in stress-induced vasopressin and oxytocin secretion Eur. J. Endocrinol. 147 2002 815 824
17. P.G. Kennedy, R.P. Lisak, and M.C. Raff Cell type-specific markers for human glial and neuronal cells in culture Lab. Invest. 43 1980 342 351
18. A. Michler-Stuke, and J.E. Bottenstein Proliferation of glial-derived cells in defined media J. Neurosci. Res. 7 1982 215 228
19. Z. Huszti, A. Rimanoczy, A. Juhasz, and K. Magyar Uptake, metabolism, and release of [3H]-histamine by glial cells in primary cultures of chicken cerebral hemispheres Glia 3 1990 159 168
20. J. Julesz, M. Gálfi, J. Molnár, and M. Vecsernyés Central effects of tricyclic compounds on the endocrine system-an in vitro study Prog. Brain Res. 91 1992 89 92
21. M. Galfi, T. Janaky, R. Toth, G. Prohaszka, A. Juhasz, and C. Varga Effects of dopamine and dopamine-active compounds on oxytocin and vasopressin production in rat neurohypophyseal tissue cultures Regul. Pept. 98 2001 49 54
22. J. Dogterom, T.B. van Wimersma Greidanus, and D. De Wied Vasopressin in cerebrospinal fluid and plasma of man, dog and rat Am. J. Physiol. 234 1978 E463 E467
23. F. Laczi, T. Ivanyi, J. Julesz, T. Janaky, and F.A. Laszlo Plasma arginine-8-vasopressin responses to osmotic or histamine stimulation contribute to the differential diagnosis of central diabetes insipidus Acta. Endocrinol. (Copenh) 113 1986 168 174
24. M. Vecsernyés, A. Török, I. Jójárt, F. Laczi, B. Penke, and J. Julesz Specific radioimmunoassay of oxytocin in rat plasma Endocr. Regul. 28 1994 145 150
25. W.M. Hunter, and F.C. Greenwood Preparation of iodine 131 labelled human growth hormone of high specific activity Nature 194 1962 495 496
26. T. Janáky, G. Tóth, B. Penke, K. Kovács, and F.A. László Iodination of peptide hormones and purification of iodinated peptides by HPLC J. Lic. Chromatogr. 5 1982 1499 1507
27. E. Friedman, D.T. Krieger, E. Mezey, C. Leranth, M.J. Brownstein, and M. Palkovits Serotonergic innervation of the rat pituitary intermediate lobe: decrease after stalk section Endocrinology 112 1983 1943 1947
28. C. Leranth, M. Palkovits, and D.T. Krieger Serotonin immunoreactive nerve fibers and terminals in the rat pituitary-light- and electron-microscopic studies Neuroscience 9 1983 289 296
29. A. Lemay, A. Brouillette, F. Denizeau, and M. Lavoie Melatonin- and serotonin-stimulated release of vasopressin from rat neurohypophysis in vitro Mol. Cell. Endocrinol. 14 1979 157 166
30. M. Holzbauer, K. Racke, and D.F. Sharman Release of endogenous 5-hydroxytryptamine from the neural and the intermediate lobe of the rat pituitary gland evoked by electrical stimulation of the pituitary stalk Neuroscience 15 1985 723 728
31. D.F. Swaab, F. Nijveldt, and C.W. Pool Distribution of oxytocin and vasopressin in the rat supraoptic and paraventricular nucleus J. Endocrinol. 67 1975 461 462
32. C.H. Rhodes, J.I. Morrell, and D.W. Pfaff Immunohistochemical analysis of magnocellular elements in rat hypothalamus: distribution and numbers of cells containing neurophysin, oxytocin and vasopressin J. Comp. Neurol. 198 1981 45 64
33. C.J. Boersma, and F.W. Van Leeuwen Neuron-glia interactions in the release of oxytocin and vasopressin from the rat neural lobe: the role of opioids, other neuropeptides and their receptors Neuroscience 62 1994 1003 1020
34. M. Galfi, L. Balaspiri, R. Toth, I. Pavo, F. Laszlo, and E. Morschl Inhibitory effect of galanin on dopamine-induced enhanced vasopressin secretion in rat neurohypophyseal tissue cultures Regul. Pept. 110 2002 17 23
35. M. Galfi, L. Balaspiri, R. Toth, I. Pavo, E. Csajbok, and F. Laszlo Inhibitory effect of galanin on dopamine induced increased oxytocin secretion in rat neurohypophyseal tissue cultures Regul. Pept. 116 2003 35 41
36. S. Hynie 5-hydroxytryptamine (serotonin) receptors-nomenclature and classification of types and subtypes Cesk. Fysiol. 44 1995 135 138
37. G. Bagdy, A.F. Sved, D.L. Murphy, and K. Szemeredi Pharmacological characterization of serotonin receptor subtypes involved in vasopressin and plasma renin activity responses to serotonin agonists Eur. J. Pharmacol. 210 1992 285 289
38. H. Jorgensen, M. Riis, U. Knigge, A. Kjaer, and J. Warberg Serotonin receptors involved in vasopressin and oxytocin secretion J. Neuroendocrinol. 15 2003 242 249
39. Z. Razzaque, J. Longmore, and R.G. Hill Differences in the effects of ketanserin and GR127935 on 5-HT-receptor mediated responses in rabbit saphenous vein and guinea pig jugular vein Eur. J. Pharmacol. 283 1995 199 206
40. J.M. Zgombick, L.E. Schechter, S.A. Kucharewicz, R.L. Weinshank, and T.A. Branchek Ketanserin and ritanserin discriminate between recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes Eur. J. Pharmacol. 291 1995 9 15
41. C.S. Aulakh, J.L. Hill, and D.L. Murphy Effects of various serotonin receptor subtype-selective antagonists alone and on m-chlorophenylpiperazine- induced neuroendocrine changes in rats J. Pharmacol. Exp. Ther. 263 1992 588 595
42. U. Knigge, E. Willems, A. Kjaer, H. Jorgensen, and J. Warberg Histaminergic and catecholaminergic interactions in the central regulation of vasopressin and oxytocin secretion Endocrinology 140 1999 3713 3719
43. A. Pap, P. Lechene dela Porte, and H. Sarles Exogenous and endogenous stimulations during different phases of pancreatic secretion in conscious rats Pflugers Arch. 383 1979 19 27
44. S. Abdelmoumene, and J.D. Gardner Cholecystokinin-induced desensitization of enzyme secretion in dispersed acini from guinea pig pancreas Am. J. Physiol. 239 1980 G272 G279
45. H.A. Stark, C.M. Sharp, V.E. Sutliff, J. Martinez, R.T. Jensen, and J.D. Gardner CCK-JMV-180: a peptide that distinguishes high-affinity cholecystokinin receptors from low-affinity cholecystokinin receptors Biochim. Biophys. Acta 1010 1989 145 150